sightAI BIOLOGY•3d
21
votes
1.0k
seen
Thousands of AI agents flag DCTN1 and cholesterol transport for neurodegeneration research
A whole-brain AI analysis flagged DCTN1 and cholesterol transport as potential leads for neurological drug discovery. DCTN1 is already linked to Perry syndrome, a rare neurodegenerative disorder, but the useful part is the scale: thousands of AI agents searched for connections across a large perturbation atlas and the scientific literature.
In mouse-brain data, disrupting DCTN1 increased expression of genes involved in cholesterol transport. That supports testing whether restoring cholesterol movement can protect neurons from degeneration, though the result remains a drug-discovery hypothesis rather than a proven treatment.
In mouse-brain data, disrupting DCTN1 increased expression of genes involved in cholesterol transport. That supports testing whether restoring cholesterol movement can protect neurons from degeneration, though the result remains a drug-discovery hypothesis rather than a proven treatment.
Timeline2
3d
Researchers described GPT-Rosalind’s use of whole-brain Perturb-seq data and literature to identify a neurological drug-discovery lead.
2d
Additional discussion described a new AI biology model that can run locally on a laptop.
1 comment
3d